Paul Smaltz

Paul Smaltz, Senior Vice President of BASF Pharma Solutions, details how the company acts as a strategic partner to the pharmaceutical industry by integrating AI-driven formulation tools, sustainability initiatives, and specialized biopharmaceutical solutions to overcome modern manufacturing challenges. 

Beyond the Excipient: Drug Formulation from Discovery Through Commercialization

As the pharmaceutical landscape shifts toward asset-light models and increased outsourcing, BASF is evolving beyond its role as a traditional excipient manufacturer to provide deep technical expertise and R&D support. Through the implementation of generative AI and the ZoomLab® predictive modeling tool, BASF is helping customers accelerate formulation timelines and solve complex bioavailability issues with unprecedented precision. Smaltz also discusses the BASF commitment to "green transformation," pointing to the company’s goal of reaching net-zero emissions by 2050 while delivering high-performance and sustainable solutions for the growing biopharmaceutical market.

Videos

Paul Smaltz, Senior Vice President of BASF Pharma Solutions, explains how the company acts as a strategic partner to the pharmaceutical industry by integrating AI-driven formulation tools, sustainability initiatives, and specialized biopharmaceutical solutions to overcome modern manufacturing challenges. 

Paul Smaltz

Articles